Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Giulia Carli

Showing results (51-60 of 66) with videos related to

Pageof 7
Sort By:
Nature Communications|September 2, 2024
Acetyl-DL-leucine in two individuals with REM sleep behavior disorder improves symptoms, reverses loss of striatal dopamine-transporter binding and stabilizes pathological metabolic brain pattern-case reportsWolfgang H Oertel, Annette Janzen, Martin T Henrich, et al.
The Journal of Venomous Animals and Toxins Including Tropical Diseases|March 24, 2022
A new therapeutic approach for bone metastasis in colorectal cancer: intratumoral melittinMackson Martins Rocha, Isabela Dariva, Gabriela Comelli Zornoff, et al.
Current Radiopharmaceuticals|May 16, 2023
Rethinking Tako-tsubo Cardiomyopathy: The Contribution of Myocardial Pathology and Molecular ImagingStelvio Sestini, Angela Coppola, Manjola Dona, et al.
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|November 21, 2025
Dietary tributyrin supplementation in Parkinson's disease: An open-label target engagement studyJeffrey L B Bohnen, Stiven Roytman, Travis P Wigstrom, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|September 27, 2023
Optimization of the diagnosis and characterization of gibberellin-regulated protein sensitization: An Italian cohort studyLorenzo Cecchi, Pascal Poncet, Lucia Maltagliati, et al.
NPJ Parkinson'S Disease|November 12, 2025
Modelling cholinergic and dopaminergic function over time in Parkinson's disease with and without GBA1 variantsSofie Slingerland, Eline K R de Meyer, Harm J van der Horn, et al.
Nature Communications|July 2, 2025
A multicenter longitudinal study of cholinergic subgroups in Parkinson diseaseNicolaas I Bohnen, Stiven Roytman, Sygrid van der Zee, et al.
Minerva Urology and Nephrology|February 16, 2026
Oncologic outcomes after robot assisted radical cystectomy in patients with clinically positive lymph nodes (cN1): a tertiary referral center experienceLuca Lambertini, Marco Saladino, Fabrizio DI Maida, et al.
Journal of Clinical Medicine|November 27, 2025
Surgical Treatment for Localized Prostate Cancer: A Narrative Review of LiteratureVincenzo Salamone, Luca Mazzola, Francesco Lupo Conte, et al.
Journal of Clinical Medicine|May 27, 2026
Evaluating Oncological Outcomes in Patients with Multiple PiRADS Lesion Treated with Robot-Assisted Radical Prostatectomy for Prostate Cancer: Results from a Large Contemporary Cohort with Centralized MpMRI Evaluation in a High-Volume CenterLuca Lambertini, Simone Sforza, Filippo Lipparini, et al.
Pageof 7

Showing results (51-60 of 66) with videos related to

Sort By:
Pageof 7
Nature Communications|September 2, 2024
Acetyl-DL-leucine in two individuals with REM sleep behavior disorder improves symptoms, reverses loss of striatal dopamine-transporter binding and stabilizes pathological metabolic brain pattern-case reportsWolfgang H Oertel, Annette Janzen, Martin T Henrich, et al.
The Journal of Venomous Animals and Toxins Including Tropical Diseases|March 24, 2022
A new therapeutic approach for bone metastasis in colorectal cancer: intratumoral melittinMackson Martins Rocha, Isabela Dariva, Gabriela Comelli Zornoff, et al.
Current Radiopharmaceuticals|May 16, 2023
Rethinking Tako-tsubo Cardiomyopathy: The Contribution of Myocardial Pathology and Molecular ImagingStelvio Sestini, Angela Coppola, Manjola Dona, et al.
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|November 21, 2025
Dietary tributyrin supplementation in Parkinson's disease: An open-label target engagement studyJeffrey L B Bohnen, Stiven Roytman, Travis P Wigstrom, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|September 27, 2023
Optimization of the diagnosis and characterization of gibberellin-regulated protein sensitization: An Italian cohort studyLorenzo Cecchi, Pascal Poncet, Lucia Maltagliati, et al.
NPJ Parkinson'S Disease|November 12, 2025
Modelling cholinergic and dopaminergic function over time in Parkinson's disease with and without GBA1 variantsSofie Slingerland, Eline K R de Meyer, Harm J van der Horn, et al.
Nature Communications|July 2, 2025
A multicenter longitudinal study of cholinergic subgroups in Parkinson diseaseNicolaas I Bohnen, Stiven Roytman, Sygrid van der Zee, et al.
Minerva Urology and Nephrology|February 16, 2026
Oncologic outcomes after robot assisted radical cystectomy in patients with clinically positive lymph nodes (cN1): a tertiary referral center experienceLuca Lambertini, Marco Saladino, Fabrizio DI Maida, et al.
Journal of Clinical Medicine|November 27, 2025
Surgical Treatment for Localized Prostate Cancer: A Narrative Review of LiteratureVincenzo Salamone, Luca Mazzola, Francesco Lupo Conte, et al.
Journal of Clinical Medicine|May 27, 2026
Evaluating Oncological Outcomes in Patients with Multiple PiRADS Lesion Treated with Robot-Assisted Radical Prostatectomy for Prostate Cancer: Results from a Large Contemporary Cohort with Centralized MpMRI Evaluation in a High-Volume CenterLuca Lambertini, Simone Sforza, Filippo Lipparini, et al.
Pageof 7